Literature DB >> 33239168

Hepatoprotective effect of apolipoprotein A4 against carbon tetrachloride induced acute liver injury through mediating hepatic antioxidant and inflammation response in mice.

Xiaoming Li1, Xiaohuan Liu1, Yupeng Zhang1, Cheng Cheng2, Jingna Fan2, Jinting Zhou2, Malgorzata A Garstka1, Zongfang Li3.   

Abstract

Apolipoprotein A4 (ApoA4) regulates lipid and glucose metabolism and exerts anti-inflammatory effects in atherogenesis and colitis. The present study explored the presumed protective role of ApoA4 in carbon tetrachloride (CCl4)-induced acute liver injury (ALI) in mice. The ALI model in wild type (WT), ApoA4 knock-out (ApoA4-KO) and ApoA4 transgenic (ApoA4-TG) mice was induced by a single intraperitoneal administration of CCl4. Liver and blood were harvested from mice to assess liver functions, immunohistological changes, immune cell populations and cytokine profiles. ApoA4 deficiency aggravated, and ApoA4 overexpression alleviated CCl4-inflicted liver damage by controlling levels of anti-oxidant enzymes. ApoA4 deletion increased the recruitment of monocytes/macrophages into the injured liver and upregulated the plasma levels of IL-6, TNF-α and MCP-1, but lower IL-10 and IFN-γ. ApoA4 over-expression rescued this effect and resulted in lower percentages of monocytes/macrophages and dendritic cells, the ratio of blood pro-inflammatory to anti-inflammatory monocytes and reduced plasma concentrations of IL-6, but enhanced IL-10 and IFN-γ. We propose ApoA4 as a potential new therapeutic target for the management of liver damage.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute liver injury; Anti-inflammatory effect; Anti-oxidative effect; Apolipoprotein A4; Cytokines

Mesh:

Substances:

Year:  2020        PMID: 33239168     DOI: 10.1016/j.bbrc.2020.11.024

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Serum APOA4 Pharmacodynamically Represents Administered Recombinant Human Hepatocyte Growth Factor (E3112).

Authors:  Sotaro Motoi; Mai Uesugi; Takashi Obara; Katsuhiro Moriya; Yoshihisa Arita; Hideaki Ogasawara; Motohiro Soejima; Toshio Imai; Tetsu Kawano
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

2.  Mechanism of hydroxysafflor yellow A on acute liver injury based on transcriptomics.

Authors:  Xiangmei Hou; Ziying Zhang; Yuehong Ma; Rong Jin; Bing Yi; Dongdong Yang; Lijie Ma
Journal:  Front Pharmacol       Date:  2022-09-02       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.